Looking to the Genome to Address ‘Undruggable’ Diseases including Parkinson’s, ALS, Cancer and More Biochemist Matthew Disney, Ph.D., has found that many incurable diseases can potentially be cured via key RNA. He’s racing against time to create novel treatments and get them to patients. Original…
A new discovery from the lab of chemist Matthew Disney, Ph.D., takes its inspiration from Greek mythology. The compound is a chimera, and it battles a toxic cause of Parkinson's in two ways.
The scientists’ approach directs cells’ recycling enzymes to cancer genes’ RNA and cuts up key segments to prevent them from doing harm. The tactic worked against the MYC cancer gene, and also two other challenging cancer genes.
January 17-18, 2023 The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology Rodney B. Fink Auditorium 120 Scripps Way, Jupiter, Florida 33458 RNA: From Biology to Drug Discovery See RNA Symposium Highlights and Photos…
A trailblazing scientist targets ALS, myotonic dystrophy, Parkinson’s, metastatic breast cancer, viral diseases and more by attacking key RNA, preventing disease-causing genes from being expressed in the first place.
Disney designed the ALS compound by applying nearly 15 years of research finding druggable structures on RNA.
Like a carpenter switching drill bits depending on the job at hand, scientists at Scripps Research in Florida have changed an investigational medicine’s activity by swapping in different molecular tools, in the process, showing a potential new way to address multiple incurable diseases.
